A new study indicates that 'Made in India' CAR-T cell therapy provides effective long-term control for patients suffering from blood cancer.
The therapy, which involves genetically modifying a patient's own immune cells to fight cancer, has shown promising results in clinical trials conducted across Indian research institutes.
This development represents a significant advancement in affordable cancer care, potentially offering a viable alternative to traditional chemotherapy for many patients.